API Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (Websockets) API Financial News API Delisted Data API
Solutions
New & Popular APIs
Show all APIs Fundamental Data APIs Indices Historical Constituents API 40 000 Stock Market Logos API Forex Data APIs
Other products
Google Sheets Add-on Excel Add-on Coding Libraries (Python, R, etc) Wordpress Add-on
API Marketplace
Community
Academy 134 articles Forum Github 13 repos
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. PINK /
  3. PKBO.PINK

Ignyte Acquisition Corp (PKBO PINK) stock market data APIs

$0.14 0(0%) as of September 10, 2024
Price chart is built with Anychart

Peak Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of patients with cancer, inflammatory, and rare diseases in the United States. The company's lead product candidate is PHP-303, which is in Phase 2 clinical study for the treatment of alpha-1 antitrypsin deficiency and acute respiratory distress syndrome. It also develops Trop2 PH1, an antibody-drug-conjugate in preclinical trials for solid tumors. Peak Bio, Inc. is based in Pleasanton, California.

Ignyte Acquisition Corp Financial Data Overview

0.14
0.14
-
0.14
0.14
0.002-0.43
3 237 K
23 125 K
354 K
-0.0899
0.223
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'PKBO',
Type: 'Common Stock',
Name: 'Ignyte Acquisition Corp',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00YVT9720',
ISIN: NULL,
CUSIP: NULL,
CIK: '1834645',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2021-03-15',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Ignyte Acquisition Corp Fundamental Data is available in our Financial Data APIs

  • Net Revenue 354 K
  • EBITDA -6 652 362
  • Earnings Per Share -0.18
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Ignyte Acquisition Corp Earnings via APIs

  • Latest Release 2024-08-28
  • EPS/Forecast NaN

Get Ignyte Acquisition Corp End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Ignyte Acquisition Corp latest news via APIs

Peak Bio, Inc. Announces Filing of Provisional Patent Applications for PH-1, a Novel and Specific Immunomodulatory ADC payload platform targeting RNA splicing

Pleasanton, CA, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Peak Bio, Inc. ("Peak Bio" or the "Company") (OTC PK: PKBO), is a clinical-stage biopharmaceutical company focused on developing and commercializi...
  • ADVISORY
  • INC
  • OTC MARKETS:PKBO
  • PEAK BIO

Peak Bio, Inc. Announces Up-listing to OTCQB Market

Pleasanton, CA, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Peak Bio, Inc. ("Peak Bio" or the "Company") (OTC PK: PKBO), is a clinical-stage biopharmaceutical company focused on developing and commercializin...
  • ADVISORY
  • EXCHANGE NEWS
  • INC
  • OTC MARKETS:PKBO
  • PEAK BIO
  • STOCK MARKET NEWS
Do you have any questions?
support@eodhistoricaldata.com